These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 31043134

  • 1. "The state of mind tells me it's dirty": menstrual shame amongst women using a vaginal ring in Sub Saharan Africa.
    Duby Z, Katz A, Musara P, Nabukeera J, Zimba CC, Woeber K, Palanee-Phillips T, van der Straten A.
    Women Health; 2020 Jan; 60(1):72-86. PubMed ID: 31043134
    [Abstract] [Full Text] [Related]

  • 2. Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe.
    Duby Z, Katz AWK, Browne EN, Mutero P, Etima J, Zimba CC, Woeber K, Atujuna M, Reddy K, van der Straten A, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2020 Feb; 24(2):617-628. PubMed ID: 31030301
    [Abstract] [Full Text] [Related]

  • 3. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297
    [Abstract] [Full Text] [Related]

  • 4. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa.
    Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, Baeten J, Katz A, Hillier S, Montgomery E, MTN-020/ASPIRE Study Team.
    BMC Womens Health; 2021 Apr 23; 21(1):175. PubMed ID: 33892693
    [Abstract] [Full Text] [Related]

  • 5. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe.
    Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, Tsidya M, Chitukuta M, Guma V, Tenza S, Leslie J, Garcia M, Naidoo S.
    AIDS Behav; 2021 Jun 23; 25(6):1890-1900. PubMed ID: 33389318
    [Abstract] [Full Text] [Related]

  • 6. Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex.
    Laborde ND, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M, Naidoo S, Palanee-Phillips T, Baeten JM, Montgomery ET, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2018 Feb 23; 22(2):437-446. PubMed ID: 29151197
    [Abstract] [Full Text] [Related]

  • 7. Women's and girls' experiences of menstruation in low- and middle-income countries: A systematic review and qualitative metasynthesis.
    Hennegan J, Shannon AK, Rubli J, Schwab KJ, Melendez-Torres GJ.
    PLoS Med; 2019 May 23; 16(5):e1002803. PubMed ID: 31095568
    [Abstract] [Full Text] [Related]

  • 8. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
    Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, Nair G, Chinula L, Parikh UM, Mellors JW, Balán IC, Ngure K, van der Straten A, Scheckter R, Garcia M, Peda M, Patterson K, Livant E, Bunge K, Singh D, Jacobson C, Jiao Y, Hendrix CW, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Torjesen K, Nel A, Rosenberg Z, Soto-Torres LE, Hillier SL, Brown ER, MTN-025/HOPE Study Team.
    Lancet HIV; 2021 Feb 23; 8(2):e87-e95. PubMed ID: 33539762
    [Abstract] [Full Text] [Related]

  • 9. Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa.
    Laher F, Todd CS, Stibich MA, Phofa R, Behane X, Mohapi L, Martinson N, Gray G.
    Contraception; 2010 Jun 23; 81(6):547-51. PubMed ID: 20472125
    [Abstract] [Full Text] [Related]

  • 10. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L.
    AIDS Behav; 2015 May 23; 19(5):784-93. PubMed ID: 25416076
    [Abstract] [Full Text] [Related]

  • 11. Women's attitudes to condoms and female-controlled means of protection against HIV and STDs in south-western Uganda.
    Hart GJ, Pool R, Green G, Harrison S, Nyanzi S, Whitworth JA.
    AIDS Care; 1999 Dec 23; 11(6):687-98. PubMed ID: 10716009
    [Abstract] [Full Text] [Related]

  • 12. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027).
    Milford C, Ramlal H, Mofokeng R, Rambally Greener L, Nel A, Smit J, Malherbe M.
    BMC Public Health; 2024 May 31; 24(1):1458. PubMed ID: 38822304
    [Abstract] [Full Text] [Related]

  • 13. Degrees of disclosure: a study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa.
    Sahin-Hodoglugil NN, van der Straten A, Cheng H, Montgomery ET, Kacanek D, Mtetwa S, Morar N, Munyoro J, Padian N, MIRA Team.
    Soc Sci Med; 2009 Nov 31; 69(10):1547-55. PubMed ID: 19765879
    [Abstract] [Full Text] [Related]

  • 14. Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa.
    Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, Tauya T, Zimba C, Etima J, Mangxilana N, Palanee-Phillips T, van der Straten A, MTN-025/HOPE Study Team.
    AIDS Behav; 2021 Dec 31; 25(12):3847-3857. PubMed ID: 34009480
    [Abstract] [Full Text] [Related]

  • 15. Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE.
    Mensch BS, Richardson BA, Husnik M, Brown ER, Kiweewa FM, Mayo AJ, Baeten JM, Palanee-Phillips T, van der Straten A, MTN-020/ASPIRE study team.
    AIDS Behav; 2019 Feb 31; 23(2):504-512. PubMed ID: 30218318
    [Abstract] [Full Text] [Related]

  • 16. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.
    BMC Res Notes; 2012 Nov 01; 5():613. PubMed ID: 23116431
    [Abstract] [Full Text] [Related]

  • 17. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M, Palanee-Phillips T, O'Rourke S, Adewumi K, Tenza S, Mathebula F, Wagner D, Ayub A, Montgomery ET.
    AIDS Care; 2019 Jun 01; 31(6):660-666. PubMed ID: 30309246
    [Abstract] [Full Text] [Related]

  • 18. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial.
    Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET, for the MTN-020/ASPIRE Team.
    AIDS Behav; 2020 May 01; 24(5):1432-1442. PubMed ID: 31667678
    [Abstract] [Full Text] [Related]

  • 19. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa.
    Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T, Tembo T, Etima J, Musara P, Mgodi NM, van der Straten A, MTN-020/ASPIRE Study Team.
    Cult Health Sex; 2019 Nov 01; 21(11):1209-1224. PubMed ID: 30657023
    [Abstract] [Full Text] [Related]

  • 20. Sexual scripting of heterosexual penile-anal intercourse amongst participants in an HIV prevention trial in South Africa, Uganda and Zimbabwe.
    Duby Z, Hartmann M, Montgomery ET, Colvin CJ, Mensch B, van der Straten A.
    Cult Health Sex; 2016 Nov 01; 18(1):30-44. PubMed ID: 26223703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.